Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strom, E. A.
Right arrow Articles by Ross, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strom, E. A.
Right arrow Articles by Ross, M. I.

Annals of Surgical Oncology, Vol 2, Issue 5 445-449, Copyright © 1995 by Society of Surgical Oncology

ARTICLES

Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control

E. A. Strom and M. I. Ross
Department of Radiotherapy, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

BACKGROUND: Certain patients with locally advanced melanoma have a high risk of regional recurrence after surgical excision and lymphadenectomy alone. Growing evidence suggests that radiation therapy may improve local control with acceptable morbidity for patients with melanoma in some sites. There is no information regarding the safety or efficacy of this treatment when applied to the axilla for regional metastasis of cutaneous melanoma. METHODS: We conducted a retrospective evaluation of patients who received postoperative radiation therapy to the axillary lymphatics for malignant melanoma at the M. D. Anderson Cancer Center between 1980 and 1992. Twenty-eight patients were identified who had undergone a formal axillary lymph node dissection followed by postoperative irradiation to the full axilla and supraclavicular fossa. Twenty-two patients were irradiated using a hypofractionated treatment regimen (4-7 Gy/fraction), generally to 30 Gy in five fractions. RESULTS: Sixteen patients are currently alive. Actuarial survival at 5 years is 50.1%. Local tumor recurred or persisted in five patients, four of whom had clinically palpable tumor when they were irradiated. CONCLUSIONS: Postoperative irradiation of the axilla for malignant melanoma has acceptable toxicity, even in those with extensive axillary dissection. In this group, patients treated for subclinical disease had a low rate of recurrence (1 of 21, [5%]).


This article has been cited by other articles:


Home page
 Arch SurgHome page
L. Lam, E. Krementz, C. McGinness, and R. Godfrey
Melanoma of the Clavicular Region: Multimodal Treatment
Arch Surg, September 1, 2001; 136(9): 1054 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
I. Pidhorecky, R. J. Lee, G. Proulx, D. R. Kollmorgen, C. Jia, D. L. Driscoll, W. G. Kraybill, and J. F. Gibbs
Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma
Ann. Surg. Oncol., March 1, 2001; 8(2): 109 - 115.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Society of Surgical Oncology.